NVGCT

The aim of the Netherlands Society of Gene & Cell Therapy is to promote both fundamental and translational research on gene & cell therapies. By bringing together all stakeholders (i.e. researchers, patients, physicians, government and regulatory authorities) the society aims to contribute to the swift development of new therapies for life-threatening diseases, including inherited diseases as well as acquired diseases such as cancer and cardiovascular diseases.

To achieve this, the society actively promotes:

  • Exchange of information and expertise between the various stakeholders
  • Public awareness of the status and possibilities of gene & cell therapy by organizing public events, workshops and lectures
  • Educational & Research-oriented sessions for researchers in the gene & cell therapy field (e.g. organisation of Spring Symposium)

Calendar

News

Duurste medicijn ter wereld komt naar Nederland

FD.nl Publicatiedatum: 27 May 2019 14:00 Rubriek: ECONOMIE & POLITIEK Lengte: 820 woorden Het Zorginstituut buigt zich waarschijnlijk dit jaar nog over de introductie in Nederland van een nieuw geneesmiddel dat sinds deze week bekendstaat als ‘duurste medicijn ter wereld’. Het medicijn dat bestemd is voor kinderen met de zeldzame spierziekte SMA, gaat in de Verenigde Staten $2,1 mln …

25 Up-and-Coming Gene Therapies of 2019

A recently published article in the Genetic Engineering and Biotechnology News website, shows that clinical trials are increasing 17% each year. In addition, a description of all the 2019 up-and-coming gene therapies is given. You can read the complete news in here.

Our Sponsors

Resultado de imagen de greiner bio-one logo   Resultado de imagen de Plasmid factory logo